Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 42

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 42
---
 each underwriter named below has severally agreed to purchase, and we have agreed to sell
to that underwriter, the number of shares of Series B Preferred Stock set forth opposite the underwriter’s name.

| Underwriters                             |     | Number of 
    Shares |
| Raymond James & Associates, Inc.         |     |   480,000 |
| BMO Capital Markets Corp.                |     |   480,000 |
| Stifel, Nicolaus & Company, Incorporated |     |   480,000 |
| Robert W. Baird & Co. Incorporated       |     |   200,000 |
| Janney Montgomery Scott LLC              |     |   120,000 |
| B. Riley Securities, Inc.                |     |    80,000 |
| Ladenburg Thalmann & Co. Inc.            |     |    80,000 |
| Berenberg Capital Markets LLC            |     |    40,000 |
| Colliers Securities LLC                  |     |    40,000 |
| Total                                    |     | 2,000,000 |

Subject to the terms and conditions set forth in the underwriting
agreement, the underwriters have agreed, severally and not jointly, to purchase all of the shares of the Series B Preferred Stock
sold under the underwriting agreement if any of these shares of Series B Preferred Stock are purchased. If an underwriter defaults,
the underwriting agreement provides that the purchase commitments of the non-defaulting underwriters may be increased or the underwriting
agreement may be terminated.

The underwriters propose to offer some of the
shares of the Series B Preferred Stock directly to the public at the public offering price set forth on the cover page of this
prospectus supplement and some of the shares of the Series B Preferred Stock to dealers at the public offering price less a concession
not to exceed $0.50 per share. The underwriters may allow, and dealers may re-allow, a concession not to exceed $0.10 per share on sales
to other dealers. If all of the shares are not sold at the initial offering price, the underwriters may change the public offering price
and the other selling terms.

We have agreed to indemnify the underwriters against
liabilities under the Securities Act or contribute to payments that the underwriters may be required to make in that respect.

Over-Allotment Option

We have granted to the underwriters an option
to purchase up to